Eyal Fenig

3.7k total citations
118 papers, 2.8k citations indexed

About

Eyal Fenig is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Eyal Fenig has authored 118 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 26 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Eyal Fenig's work include Polyomavirus and related diseases (24 papers), Antenna Design and Analysis (15 papers) and Full-Duplex Wireless Communications (13 papers). Eyal Fenig is often cited by papers focused on Polyomavirus and related diseases (24 papers), Antenna Design and Analysis (15 papers) and Full-Duplex Wireless Communications (13 papers). Eyal Fenig collaborates with scholars based in Israel, United States and United Kingdom. Eyal Fenig's co-authors include Aarón Sulkes, Baruch Brenner, Jardena Nordenberg, Haim Gutman, Einat Beery, Jaqueline Sulkes, Joachim Yahalom, Meora Feinmesser, Erica Rakowsky and Robert Wieder and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eyal Fenig

114 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyal Fenig Israel 33 1.3k 736 394 369 366 118 2.8k
Dorothée Nashan Germany 23 687 0.5× 675 0.9× 95 0.2× 428 1.2× 106 0.3× 60 2.0k
Wolfram E. Samlowski United States 34 1.6k 1.3× 1.5k 2.0× 86 0.2× 281 0.8× 680 1.9× 154 3.7k
Kimiko Nakajima Japan 23 370 0.3× 364 0.5× 59 0.1× 260 0.7× 116 0.3× 102 2.0k
Luciano Mutti Italy 38 1.2k 0.9× 1.3k 1.7× 88 0.2× 164 0.4× 2.9k 8.0× 153 4.9k
Gang Zeng United States 22 441 0.3× 1.3k 1.8× 67 0.2× 289 0.8× 132 0.4× 50 2.3k
M. Angélica Selim United States 24 691 0.5× 529 0.7× 33 0.1× 417 1.1× 144 0.4× 73 2.0k
Marta Bueno United States 23 170 0.1× 877 1.2× 68 0.2× 377 1.0× 1.2k 3.3× 54 2.4k
Raffaele De Palma Italy 38 1.1k 0.8× 1.3k 1.7× 33 0.1× 498 1.3× 505 1.4× 118 4.9k
Fernando Schmitt Portugal 32 1.0k 0.8× 1.1k 1.5× 19 0.0× 352 1.0× 565 1.5× 155 3.6k
Wei Guo China 35 1.2k 1.0× 2.3k 3.1× 47 0.1× 284 0.8× 824 2.3× 174 4.2k

Countries citing papers authored by Eyal Fenig

Since Specialization
Citations

This map shows the geographic impact of Eyal Fenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Fenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Fenig more than expected).

Fields of papers citing papers by Eyal Fenig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Fenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Fenig. The network helps show where Eyal Fenig may publish in the future.

Co-authorship network of co-authors of Eyal Fenig

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Fenig. A scholar is included among the top collaborators of Eyal Fenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Fenig. Eyal Fenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Doweck, Ilana, Aron Popovtzer, Daniel Hendler, et al.. (2023). First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma – A real-world experience from Israel. Frontiers in Oncology. 13. 1117804–1117804. 11 indexed citations
3.
Kundel, Yulia, Yuval Nachalon, Hanoch Kashtan, et al.. (2023). The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer. Frontiers in Oncology. 13. 1080089–1080089. 2 indexed citations
4.
Walker, John, Célèste Lebbé, Giovanni Grignani, et al.. (2020). Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program. Journal for ImmunoTherapy of Cancer. 8(1). e000313–e000313. 52 indexed citations
5.
Allen, Aaron M., Tzippy Shochat, Dov Flex, et al.. (2018). High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung Cancer. Oncology. 95(1). 13–19. 4 indexed citations
6.
Pavlovsky, Lev, et al.. (2015). Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp. Journal of the American Academy of Dermatology. 73(5). 799–801. 7 indexed citations
7.
Dickman, Ram, Yulia Kundel, Ofer Purim, et al.. (2013). Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study. Radiation Oncology. 8(1). 278–278. 13 indexed citations
8.
Kundel, Yulia, Nicola J. Nasser, Ofer Purim, et al.. (2013). Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin. PLoS ONE. 8(7). e68327–e68327. 6 indexed citations
9.
Abramson, Evgeny, et al.. (2012). Birth month of patients with malignant neoplasms: links to longevity?. Journal of Basic and Clinical Physiology and Pharmacology. 23(2). 57–60. 3 indexed citations
10.
Kundel, Yulia, Ofer Purim, Efraim Idelevich, et al.. (2011). Postoperative chemoradiation for resected gastric cancer - is the Macdonald Regimen Tolerable? a retrospective multi-institutional study. Radiation Oncology. 6(1). 127–127. 13 indexed citations
11.
Shirvan, Anat, Hagit Grimberg, Galit Levin, et al.. (2008). Monitoring of tumor response to therapy by 18F-ML-10, a novel small-molecule PET tracer for apoptosis: From preclinical to clinical studies. Clinical Cancer Research. 14. 1 indexed citations
12.
Loven, David, Ruth Hardoff, Adam Steinmetz, et al.. (2004). Non-Resectable Slow-Growing Meningiomas Treated by Hydroxyurea. Journal of Neuro-Oncology. 67(1-2). 221–226. 66 indexed citations
13.
Brenner, Baruch, et al.. (2003). High Dose Rate Brachytherapy for Nonmalignant Airway Obstruction. CHEST Journal. 124(4). 1605–1610. 11 indexed citations
14.
Brenner, Baruch, Erica Rakowsky, Meora Feinmesser, et al.. (2001). Second neoplasms in patients with Merkel cell carcinoma. Cancer. 91(7). 1358–1362. 68 indexed citations
15.
Wasserberg, Nir, et al.. (2000). Applicability of the Sentinel Node Technique to Merkel Cell Carcinoma. Dermatologic Surgery. 26(2). 138–141. 50 indexed citations
16.
Nordenberg, Jardena, et al.. (1999). Effects of psychotropic drugs on cell proliferation and differentiation. Biochemical Pharmacology. 58(8). 1229–1236. 91 indexed citations
17.
Salman, Hertzel, Michael Bergman, Hanna Bessler, et al.. (1999). Decreased phagocytic capacity of rat peritoneal macrophages following photon abdominal irradiation. Cancer Letters. 147(1-2). 175–179. 10 indexed citations
18.
Wang, Qin, Paul Maloof, Huisheng Wang, et al.. (1998). Basic Fibroblast Growth Factor Downregulates Bcl-2 and Promotes Apoptosis in MCF-7 Human Breast Cancer Cells. Experimental Cell Research. 238(1). 177–187. 57 indexed citations
19.
Fenig, Eyal, et al.. (1997). The role of radiation therapy and chemotherapy in the treatment of merkel cell carcinoma. Cancer. 80(5). 881–885. 109 indexed citations
20.
Fenig, Eyal, H. Lurie, & Aarón Sulkes. (1993). The Use of Cyclophosphamide, Methotrexate, and 5-Fluorouracil in the Treatment of Merkel Cell Carcinoma. American Journal of Clinical Oncology. 16(1). 54–57. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorothée Nashan Breakdown of academic impact, for papers by Wolfram E. Samlowski Breakdown of academic impact, for papers by Kimiko Nakajima Breakdown of academic impact, for papers by Luciano Mutti Breakdown of academic impact, for papers by Gang Zeng Breakdown of academic impact, for papers by M. Angélica Selim Breakdown of academic impact, for papers by Marta Bueno Breakdown of academic impact, for papers by Raffaele De Palma Breakdown of academic impact, for papers by Fernando Schmitt Breakdown of academic impact, for papers by Wei Guo
Rankless by CCL
2026